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Summary: Oxidative stress and excitotoxicity have been im-
plicated in selective striatal vulnerability caused by the mito-
chondrial toxin, 3-nitropropionic acid (3-NP), which may simu-
late Huntington’s disease in animals and humans. The detailed
mechanism of the role of superoxide in striatal vulnerability
induced by 3-NP is still unknown. The authors investigated
oxidative cellular injury and DNA fragmentation after systemic
3-NP injection in wild-type (Wt) mice and mutant mice with a
deficiency in manganese superoxide dismutase (MnSOD; Sod2
−/+). Furthermore, they investigated the effects of decortication
after 3-NP treatment in Sod2 −/+ mice, and copper/zinc SOD
(CuZnSOD) treatment in recently developed Sod2 −/+ mice
that overexpress CuZnSOD (SOD1 +/− / Sod2 −/+ mice). Oxi-
dized hydroethidine, 8-hydroxyguanosine immunoreactivity,
and nitrotyrosine immunoreactivity were increased in the Sod2
−/+ mice compared with the Wt mice after 3-NP treatment (P
< 0.001). Decortication completely abolished oxidative striatal
damage after 3-NP treatment in the Sod2 −/+ mice. Increased
CuZnSOD attenuated DNA fragmentation and striatal lesion
volume after 3-NP treatment in the Sod2 −/+ mice (P < 0.001).
These data suggest that production of superoxide may be a
critical step to excitotoxicity and subsequent DNA fragmenta-
tion in selective striatal vulnerability after 3-NP treatment. Key
Words: Superoxide—Excitotoxicity—3-Nitropropionic acid—
Striatal vulnerability—Huntington’s disease.
Mitochondrial dysfunction, excitotoxicity, and oxida-
tive stress are interacting processes in the pathogenesis
of neurodegenerative diseases such as Huntington’s dis-
ease (HD), Parkinson’s disease, amyotrophic lateral scle-
rosis, and Alzheimer’s disease (Albin and Greenamyre,
1992; Beal, 1992, 2000). There is evidence of a close
relation between oxidative stress (superoxide anion, in
particular) and excitotoxicity in neuronal cell death in-
duced by NMDA or kainic acid, which was attenuated by
CuZnSOD (Schulz et al., 1995; Kondo et al., 1997). It
has also been reported that NMDA-receptor activation
leads to superoxide production in cultured cerebellar
neurons (Dykens, 1994).
3-Nitropropionic acid, an irreversible inhibitor of mi-
tochondrial complex II (succinate dehydrogenase), is
known to produce selective striatal damage and clinical
features of HD in humans and animals (Coles et al.,
1979; Ludolph et al., 1991; Brouillet et al., 1995). Pre-
vious reports show that selective striatal lesions induced
by 3-NP could be produced by secondary excitotoxicity
(Beal et al., 1993; Schulz et al., 1996; Lee et al., 2000),
and that oxidative stress plays a substantial role in the
neurotoxicity caused by 3-NP (Beal et al., 1995; Schulz
et al., 1996; Kim et al., 2000a), suggesting that coopera-
tive pathways of excitotoxicity and oxidative stress may
be involved in selective striatal vulnerability caused by
3-NP. Moreover, other reports suggest that the form of
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excitotoxic neuronal cell death induced by 3-NP or HD
involves both apoptosis and necrosis (Pang and Geddes,
1997; Sato et al., 1997; Keller et al., 1998a).
Overexpression of the cytosolic antioxidant, CuZn-
SOD (or SOD1), plays a protective role in oxidative
striatal lesions after 3-NP treatment (Beal et al., 1995). A
deficiency in another mitochondrial antioxidant, manga-
nese SOD (MnSOD or SOD2), increases striatal lesions
after 3-NP treatment (Andreassen et al., 2001). Our stud-
ies using mutant mice with an MnSOD deficiency (Sod2
−/+) showed that reduced MnSOD activity exacerbates
glutamate toxicity in cortical cell cultures (Li et al.,
1998), and that overproduction of superoxide anion radi-
cal (O2•−) increases infarction volume and triggers an
apoptotic pathway after permanent focal cerebral ische-
mia (Murakami et al., 1998; Fujimura et al., 1999) or
transient cerebral ischemia (Kim et al., 2002), suggesting
that O2•− overproduced from mitochondria may induce
excitotoxic cell death. The detailed mechanism of O2•−,
however, has not been clearly determined in the selective
striatal vulnerability after 3-NP treatment. To clarify this
issue, we investigated O2•− production, oxidative cellular
injury, DNA fragmentation, and subsequent striatal dam-
age after 3-NP treatment in both wild-type (Wt) and
Sod2 −/+ mice, and the interaction between excitotoxic-
ity and O2•− production using decorticated Sod2 −/+
mice, which removed the corticostriatal glutamate input
(Kim et al., 2000a). We further confirmed the involve-
ment of O2•− in the preferential striatal damage induced
by 3-NP using recently developed Sod2 −/+ mice that
overexpress CuZnSOD (SOD1 +/− / Sod2 −/+) (Copin et
al., 2000).
MATERIALS AND METHODS
Preparation of 3-nitropropionic acid and animals
3-Nitropropionic acid (Aldrich Chemical Co., Milwaukee,
WI, U.S.A.) was dissolved in saline to a concentration of 25
mg/mL (pH 7.4) and passed through a 0.2-m filter to remove
any bacterial contamination. This solution was administered by
intraperitoneal injection twice daily for 5 days at a dose of 50
mg/kg. Twenty-four hours after the last injection, the animals
were anesthetized with xylazine (4 mg/kg) and chloral hydrate
(350 mg/kg) and decapitated. The Sod2 gene knockout mutants
(heterozygous) with a CD1 background were backcrossed with
CD1 mice for at least 10 generations, and littermate Wt mice
with the identical genetic background (3-month-old males, 35
to 40 g) were subjected to each experiment (Li et al., 1998).
Sod2 genotypes were determined on tail DNA obtained by
proteinase K digestion followed by polymerase chain reaction
amplification of mutant and normal fragments of exon 3 of
the MnSOD gene using three primers, one shared (5-
CGAGGGGCATCTAGTGGAGAAG-3), one for the mutant
allele (5-CACACATCGGGAAAATGGTTTG-3), and one
for the normal allele (5-TTAGGGCTCAGGTTTGTC-
CAGAA-3) as previously described (Li et al., 1998). There
were no differences in morphologic, physiologic, or biochemi-
cal changes, including anatomy of the cerebral vasculature, and
cytochrome c oxidase, succinate dehydrogenase, or aconitase
activity between the Sod2 −/+ mice and the Wt littermates.
There were no compensatory increases in CuZnSOD activity in
the Sod2 heterozygous mice despite the fact that only a 50%
level of MnSOD activity was observed in various organs
(Chan, 1996; Chan et al., 1996). MnSOD heterozygous knock-
out mice with overexpressed CuZnSOD (SOD1 +/− / Sod2 −/+
mice) were obtained by backcrossing between Sod2 heterozy-
gous female mutant mice and Sod1 heterozygous transgenic
male mice (Copin et al., 2000). Heterozygous Sod1 transgenic
mice carrying human Sod1 genes with a threefold increase in
CuZnSOD were derived from the founder stock as previously
described (Epstein et al., 1987). CuZnSOD genotypes were
determined by nondenaturing gel electrophoresis of blood
samples to reveal the presence of human CuZnSOD as previ-
ously described (Chan et al., 1998). In a preevaluating study of
the Sod2 −/+ mice with overexpressed CuZnSOD, phenotype
and enzyme activity were determined to be compatible with the
data known for each genotype (Copin et al., 2000). To remove
the corticostriatal glutamate input from the striatum, decortica-
tion was performed in the Sod2 −/+ mice using a previously
described method (Kim et al., 2000a). The mice were anesthe-
tized with chloral hydrate (350 mg/kg) and xylazine (4 mg/kg)
and were fixed in a stereotaxic frame. The scalp was incised on
the midline and the skull was exposed and carefully removed
with a dental drill under surgical microscopy. The dorsolateral
aspects of the left frontoparietal lobe were removed by suction
down to the white matter. The decorticated mice were kept for
1 month before being used in further experiments, to allow the
extracellular glutamate pool to decrease. All procedures were
in accordance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals and were approved
by Stanford University’s Administrative Panel on Laboratory
Animal Care.
In situ detection of O2•− production
Production of O2•− in the striatum after injection of 3-NP
was investigated using a previously reported method with
modification (Chan et al., 1998; Murakami et al., 1998; Bruce-
Keller et al., 1999; Fujimura et al., 1999; Kim et al., 2000a,b,
2001a,b, 2002; Kim and Chan, 2001). Previous reports provide
evidence of hydroethidine-specific oxidation by O2•−, where
hydroethidine was oxidized to fluorescent red ethidium by O2•−
(Rothe and Valet, 1989), or where hydroethidine was selec-
tively oxidized to ethidium by O2•−, but not by O2, H2O2, or
peroxynitrite (Bindokas et al., 1996), or where hydroethidine
was rapidly oxidized to ethidium by O2•−, whereas oxidation by
O2 or H2O2 was much slower (Benov et al., 1998). After treat-
ment with 3-NP for 2 days, the animals were anesthetized as
described herein, and then hydroethidine (200 L; stock solu-
tion of hydroethidine [Molecular Probes, Eugene, OR, U.S.A.],
100 mg/mL in dimethyl sulfoxide, diluted to 1 mg/mL with
phosphate-buffered saline [PBS] and sonicated in a water bath)
was administered intravenously through the jugular vein using
a surgical microscope. Two hours after the hydroethidine in-
jection, the animals were killed by transcardial perfusion with
200 mL of 10 U/mL heparin in saline and 200 mL of 3.7%
formaldehyde in PBS. After postfixation overnight, the brains
were sectioned 50 m thick on a vibratome at the level of the
midstriatum and were placed on a glass slide. The brain sec-
tions were incubated with 2.5 × 10−3 mg/mL Hoechst 33258
(Molecular Probes) in PBS for 15 minutes in a dark chamber,
and then they were rinsed in distilled H2O and mounted with
Aquamount (Shandon, Pittsburgh, PA, U.S.A.). These sections
were observed with a fluorescent light microscope (HBO;
Zeiss, Thornwood, NY, U.S.A.). Photomicrographs of the fluo-
rescent microscopy were taken with a digital camera system
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(AxioVision; Zeiss) and with single and double exposure to
oxidized hydroethidine and Hoechst 33258 in the striatum of
each group. The intensity and expression patterns of the oxi-
dized hydroethidine were observed and compared in the stria-
tum between the groups. To quantify O2•− production, cells
with oxidized hydroethidine that extended to the perinuclear
area (before treatment) or the cytosol (after 3-NP treatment)
were counted and averaged in the entire field after randomly
taking them from four different sites under high magnification
(×400) using an image analysis program (AxioVision; Zeiss),
and the percentage of these cells to the total cells stained with
Hoechst nuclear staining was calculated.
Detection of oxidative DNA damage
To further confirm the involvement of oxidative stress in the
lesioned striatum after 3-NP treatment, we evaluated DNA oxi-
dation using a monoclonal antibody against 8-hydroxyguano-
sine as previously reported, with modification (Kim et al.,
2001a). The frozen sections, cut to 20 m, were mounted on
slides and dried overnight at 45°C on a slide warmer. Samples
were immersed for 10 minutes in 70% ethanol at −20°C and
then washed in PBS. In optional steps, some samples were
treated with DNase-free RNase in buffer (50 mmol/L Tris-HCl,
10 mmol/L MgCl2), or with RNase-free DNase in buffer, or
DNase and RNase in buffer, or buffer only, for 1 hour at 37°C.
Samples were denatured in 4N HCl for 7 minutes and neutral-
ized by soaking in 50 mmol/L Tris-base. After washing, the
primary antibody was applied. Samples were incubated with
mouse monoclonal antibody for 8-hydroxyguanosine (1:300;
QED Bioscience, San Diego, CA, U.S.A.) after biotinylation
and a blocking procedure, which followed the manufacturer’s
protocol, to avoid cross-reaction between the secondary anti-
body and mouse immunoglobulin G in the tissue (DAKO ARK;
Dako, Carpinteria, CA, U.S.A.). After development with di-
aminobenzidine (DAB), the sections were mounted on slides
and counterstained with methyl green solution. For comparison
of 8-hydroxyguanosine density on the RNase- or DNase-treated
samples or both, counterstaining was omitted and they were
expressed as a positive number of cells per 5 × 5-mm grid
under a ×400 magnification field.
Immunohistochemistry of nitrotyrosine
After 3-NP treatment for 5 days, the anesthetized animals
were killed by transcardial perfusion with 200 mL of 10 U/mL
heparin in saline and 200 mL of 3.7% formaldehyde in PBS.
After postfixation in 3.7% formaldehyde, the brains were sec-
tioned at 50 m on a vibratome and processed for immunohis-
tochemistry for nitrotyrosine using a previously reported pro-
cedure with modification (Ayata et al., 1997). The sections
were incubated with mouse monoclonal antibody for nitroty-
rosine (1:100; Upstate Biotechnology, Lake Placid, NY,
U.S.A.) after biotinylation and a blocking procedure, which
followed the manufacturer’s protocol, to avoid cross-reaction
between the secondary antibody and mouse immunoglobulin G
in the tissue (DAKO ARK). After development with DAB, the
sections were mounted on slides and counterstained with meth-
yl green solution. As a negative control, the sections were
incubated without the primary antibody or preabsorption pro-
cess using nitrotyrosine-blocking peptides to confirm the speci-
ficity of the antibodies, following a previously reported method
(Estevez et al., 1998). To evaluate the relation between nitro-
tyrosine formation and superoxide anion, we performed double
staining of oxidized hydroethidine and nitrotyrosine immuno-
histochemistry after 3-NP treatment for 5 days using a previ-
ously reported method with modification (Kim and Chan,
2001). Oxidized hydroethidine in situ was performed as de-
scribed earlier and nitrotyrosine immunohistochemistry was
also performed as described earlier until primary antibody in-
cubation; then the samples were washed with PBS with 0.3%
Triton X-100, and fluorescent avidin DCS (50 mg/mL; Vector
Laboratories, Burlingame, CA, U.S.A.) was applied. The sec-
tions were rinsed in distilled H2O and mounted with Aqua-
mount (Shandon). These sections were observed with a fluo-
rescent light microscope (HBO, Zeiss), and photomicrographs
of the fluorescent microscopy were taken in the striatum with
double exposure to oxidized hydroethidine and fluorescent
staining of nitrotyrosine.
Histologic evaluation and in situ detection of
DNA-fragmented cells
After euthanasia, the brains were removed and sectioned at
20-m intervals on a cryostat. To measure the lesion volume,
frozen brain sections were taken at intervals of 500 m and
stained with cresyl violet. The striatum and the unstained area
were measured in each section using Multi-Analyst software
(Bio-Rad, Hercules, CA, U.S.A.) after scanning a sample slide
with a GS-700 imaging densitometer (Bio-Rad). The striatum
and lesion volumes were calculated by multiplying each mea-
sured area by the distance. Adjacent sections from the middle
of the striatum were identified and used for the TUNEL method
to detect DNA fragmentation in situ. The procedure was carried
out by a previously described method (Kim et al., 2000a). The
sections were air dried and fixed for 30 minutes in 3.7% form-
aldehyde in 0.1 mol/L PBS. The slides were incubated in 0.3%
Triton X-100 in PBS for 30 minutes. After rinsing the sections
in PBS, they were equilibrated for 15 minutes in TdT buffer
containing 2.5 mmol/L cobalt chloride and 200 mmol/L potas-
sium cacodylate (Roche Diagnostics, Indianapolis, IN, U.S.A.).
The labeling reaction was performed at 37°C for 1 hour with
TdT (300 U/mL; Gibco BRL, Gaithersburg, MD, U.S.A.) and
40 mol/L of biotinylated 14-deoxyadenosine triphosphate
(Gibco BRL) in TdT buffer. The sections were washed twice
for 15 minutes in a PBS solution containing 150 mmol/L so-
dium chloride, 15 mmol/L sodium citrate, and 2% bovine se-
rum albumin (pH 7.4). Thereafter, the sections were incubated
with a complex of avidin and biotinylated horseradish peroxi-
dase (Vectastain Elite ABC Kit, Vector) for 30 minutes. The
samples were then washed with 0.175 mol/L sodium acetate,
and TUNEL labeling was visualized using diaminobenzidine
(0.25 g/L) and nickel chloride (10 g/L). The sections were
dehydrated in an ascending ethanol series, immersed in xylene
and coverslipped with Permount (Fisher Scientific, Pittsburgh,
PA, U.S.A.). Slides were observed with either bright-field or
dark-field phase-contrast microscopy (Diaphot-TMD; Nikon,
Tokyo, Japan). In the latter, a yellow filter was used for detec-
tion of fluorescent isothiocyanate, without excitation following
previous methods (Kim et al., 2000a).
DNA extraction and gel electrophoresis
Thirty milligrams wet weight of the lesioned or control stria-
tum were taken 24 hours after treatment with 3-NP or normal
saline for 5 days, and samples were incubated overnight in 0.6
mL of lysis buffer (0.5% sodium dodecyl sulfate, 10 mmol/L
Tris-HCl, and 0.1 mol/L EDTA) with 0.6 mg of proteinase K
(Roche Diagnostics) at 55°C. The DNA was extracted with
equal volumes of phenol and phenol-chloroform-isoamyl alco-
hol (25:24:1) and precipitated overnight in 0.2 mol/L sodium
chloride in 100% ethanol at 80°C. The DNA was washed twice
with 75% ethanol, air dried, and resuspended in DNase-free
water (Sigma, St. Louis, MO, U.S.A.). The DNA concentration
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was measured using TO-PRO-1 dye (Molecular Probes). Gel
electrophoresis for detecting DNA laddering was performed
according to the manufacturer’s instructions (Trevigen, Gai-
thersburg, MD, U.S.A.). Before electrophoresis, 1 g of DNA
was incubated with 50 g/mL DNase-free RNase (Roche Di-
agnostics) for 30 minutes at 37°C. Then the samples were
reacted with Klenow enzyme (Trevigen) and dNTP (Trevigen)
in 1× Klenow buffer (Trevigen) for 10 minutes at room tem-
perature. Samples were mixed with a loading buffer and sub-
jected to electrophoresis on a 1.5% agarose gel. Then the gel
was washed with 0.25 mol/L HCl, 0.4 mol/L NaOH, or 0.8
mol/L NaCl, and 0.5 mol/L Tris buffer, pH 7.5. DNA was
transferred to a nylon membrane overnight in 10× saline–
sodium citrate. The membrane was first blocked by 5% pow-
dered milk (Bio-Rad) in PBS for 30 minutes and incubated with
streptavidin-horseradish peroxidase conjugate (Trevigen) for
30 minutes. Finally, the bands were visualized by the chemi-
luminescence method using PeroxyGlow (Trevigen), and the
films were exposed to x-ray film. The bands of both genomic
DNA and 200 bp ladder were scanned by a GS-700 imaging
densitometer (Bio-Rad) and were analyzed using Multi-Analyst
software (Bio-Rad).
Quantitation and statistical analysis
A blinded observer counted the number of TUNEL-positive
cells in ×400 magnification of a light-field microgram. The
positive cells were carefully determined using previously re-
ported criteria (Kim et al., 2000a; Kim and Chan, 2001).
TUNEL-labeled cells were quantified with a light microscope.
They were counted in the middle and lateral parts of both
midstriatum with high-powered magnification (×400) and av-
eraged with each counted number in four parts. The number of
TUNEL-labeled cells was expressed as per millimeter squared
in each experiment. The lesion volume percent was calculated
by lesion volume to striatal volume ×100 to remove any edema-
tous effects. 8-Hydroxyguanosine- or nitrotyrosine-positive
cells were counted and quantified and were expressed as a
percentage of 8-hydroxyguanosine–positive cells per total cells.
Data are expressed as mean ± SD. Statistical comparisons
among multiple groups were made using analysis of variance
followed by Fisher’s post hoc protected least-significant differ-
ence test, whereas comparisons between two groups were per-
formed using the unpaired t test (StatView 4.5; SAS Institute,
Cary, NC, U.S.A.).
RESULTS
Detection of O2•− in the striatum using
hydroethidine oxidation
Production of O2•− was determined using hydroethi-
dine in situ detection before or after 3-NP treatment for
2 days. Oxidized hydroethidine signals, as an indication
of mitochondrial production of O2•−, were visible as
small red particles. Before 3-NP treatment, oxidized hy-
droethidine signals, as a basal level of O2•−, were barely
detected in the Wt mice (Fig. 1A), and normal intact cells
without oxidized hydroethidine signals were shown un-
der a high magnification field (Fig. 1A, inset). Under low
magnification, slightly oxidized hydroethidine signals
were diffusely distributed in the striatum of the Sod2 −/+
mice (Fig. 1B) and were expressed in the perinuclear
area using Hoechst and ethidium double exposure (Fig.
1B, inset). After 3-NP treatment for 2 days, oxidized
hydroethidine signals were widely detected in the stria-
tum, particularly in the lateral part (Figs. 1C and 1D,
arrowheads), and were more intense and frequently iden-
tified in the Sod2 −/+ mice compared with the Wt mice,
under low magnification. Overproduced oxidized hydro-
ethidine extended into the cytosol and was detected more
in the Sod2 −/+ mice than in the Wt mice using double
exposure in both oxidized hydroethidine and Hoechst
staining (Figs. 1E and 1F). Oxidized hydroethidine sig-
nals extended into the cytosol and were clearly seen un-
der high magnification (Fig. 1F, inset). Next, we quan-
tified and compared the basal level of O2•− before 3-NP
treatment and overproduction of O2•− after 3-NP treat-
ment in the Wt and Sod2 −/+ mice. Before the treatment,
cells with perinuclear oxidized hydroethidine signals
were detected significantly more often in the Sod2 −/+
mice than in the Wt mice (Fig. 1G). After treatment, the
cells with oxidized hydroethidine signals that extended
into the cytosol were significantly increased in the Sod2
−/+ mice compared with the Wt mice (Fig. 1H).
Oxidative DNA injury was increased in
Sod2 −/+ mice
To evaluate whether oxidative DNA injury occurred
after 3-NP treatment, we performed 8-hydroxyguanosine
immunohistochemistry in Wt and Sod2 −/+ mice. 8-Hy-
droxyguanosine-positive cells, seen as a granular pattern
in the nucleus and cytosol, were more extensively de-
tected in the lesioned striatum of the Sod2 −/+ mice after
3-NP treatment for 5 days than in the Wt mice (Figs. 2A
and 2B). The nonlesioned area had no 8-hydroxyguano-
sine immunoreactivity in either the Wt or Sod2 −/+ mice
(Figs. 2C and 2D). Because the 8-hydroxyguanosine an-
tibody recognized both hydroxyl radical–modified DNA
and RNA, we treated the sections with RNase, DNase,
RNase and DNase, or buffer, respectively, 24 hours after
induction of ischemia in the Wt mice, and performed
8-hydroxyguanosine immunohistochemistry. As illus-
trated in Fig. 2E, the RNase-treated samples showed in-
creased density of 8-hydroxyguanosine immunoreactiv-
ity. Treatment with DNase resulted in almost abolished
immunostaining (Fig. 2E). Samples treated with both
RNase and DNase resulted in no 8-hydroxyguanosine
immunoreactivity (Fig. 2E), and buffer-treated samples
showed an intense density of 8-hydroxyguanosine im-
munoreactivity (Fig. 2E) (RNase, 18.25 ± 0.58; DNase,
2.18 ± 0.23; RNase + DNase, not detected; buffer, 21.32
± 0.54; mean ± SD of 8-hydroxyguanosine-positive cells
per 5 × 5-mm grid). These data confirm that 8-hydroxy-
guanosine immunoreactivity mainly resulted from DNA
oxidation. To quantify oxidative cellular damage, we
counted the 8-hydroxyguanosine–positive cells to total
cells. As illustrated in Fig. 2F, the Sod2 −/+ mice had a
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more significantly increased percentage of 8-hydroxy-
guanosine-positive cells in the lesioned striatum 24 hours
after treatment than the Wt mice.
Nitrotyrosine immunoreactivity was increased in
Sod2 −/+ mice after 3-nitropropionic acid treatment
To assess the production of nitrotyrosine after 3-NP
treatment, nitrotyrosine immunohistochemistry was per-
formed in both the Wt and Sod2 −/+ mice. After 3-NP
treatment for 5 days, there was a marked increased in
immunohistochemical expression of nitrotyrosine within
the lesioned striatum of the Sod2 −/+ mice compared
with the Wt mice (Figs. 3A and 3B). Nitrotyrosine im-
munoreactivity was not observed in the nonlesioned
striatum in either group (Figs. 3C and 3D). After the
preabsorption procedure the sections showed no nitroty-
rosine immunoreactivity. To evaluate the spatial relation
between O2•− production and nitrotyrosine formation,
double staining using nitrotyrosine immunohistochemis-
try and hydroethidine in situ was performed after 3-NP
treatment for 5 days. With fluorescent avidin staining,
nitrotyrosine immunolabeled cells (Fig. 3E, green) had
oxidized hydroethidine signals that were red (Fig. 3F),
and the overlapping section was yellow (Fig. 3G). This
confirmed that O2•− might be related to the formation of
nitrotyrosine in oxidative damaged cells. To compare
nitrotyrosine formation between the Wt and Sod2 −/+
mice, we counted 8-hydroxyguanosine-positive cells to
total cells in both groups. After the treatment, cells with
nitrotyrosine immunoreactivity were significantly in-
creased in the Sod2 −/+ mice compared with the Wt mice
(Fig. 3H).
Increased DNA laddering in Sod2 −/+ mice after
3-NP treatment
To confirm apoptotic cell death after 3-NP treatment,
we analyzed the DNA isolated from both the lesioned
and control striatum after 3-NP treatment for 5 days. As
illustrated in Fig. 4A, DNA gel electrophoresis showed
signs of internucleosomal fragmentation, evident by a
laddering pattern caused by cleavage into segments that
were multiples of approximately 200 bp in length, which
is consistent with apoptosis. Some random fragmentation
was also accompanied by laddering, evident by an over-
lying continuous smear of DNA, which is consistent with
necrosis. The amount of DNA laddering was markedly
increased in the Sod2 −/+ mice (Fig. 4A, lane 3) com-
pared with the Wt mice (Fig. 4A, lane 4). Similar results
were obtained in 10 independent studies. Correspond-
ingly, there were strongly TUNEL-labeled cells accom-
panied by small particles around the nuclei that
FIG. 1. Representative findings showing increased production of
O2•− by the expression of oxidized hydroethidine in Sod2 −/+
mice. The expression of oxidized hydroethidine signals (small red
particles) before 3-NP treatment (A and B) and after 3-NP treat-
ment for 2 days (C to F). Oxidized hydroethidine signals at the
basal level were barely detected in the striatum of wild-type (Wt)
mice (A). The intact nucleus (blue) without oxidized hydroethidine
signals is shown under high magnification using Hoechst and
oxidized hydroethidine double exposure (A, inset). Oxidized hy-
droethidine signals at the basal level were slightly increased in
the striatum of Sod2 −/+ mice (B) and were particularly located in
the perinuclear area under high magnification (B, inset). After
3-NP treatment, oxidized hydroethidine signals were widely de-
tected in the striatum of the Wt mice (arrowheads) (C), and were
more intensely identified in the striatum of the Sod2 −/+ mice
(arrowheads) (D). Under high magnification using double expo-
sure for both oxidized hydroethidine and Hoechst staining, oxi-
dized hydroethidine signals into the cytosol were intermittently
detected in the Wt mice (E). Cells with oxidized hydroethidine
signals that extended into the cytosol were widely detected (F),
and overproduced oxidized hydroethidine signals are clearly
seen in the cytosol (F, inset). Bars = 150 µm in A to D; 20 µm in
E and F; 12 µm in insets. Semiquantitation of oxidized hydroethi-
dine signals at the basal level and after 3-NP treatment (G and
H). Percentage of cells with oxidized hydroethidine signals to
total cells before 3-NP treatment in the striatum (G) and percent-
age of cells with oxidized hydroethidine into the cytosol to total
cells after 3-NP treatment for 2 days (H) were calculated. Data
represent mean ± SD (n = 20 in Wt or Sod2 −/+ mice before 3-NP
treatment; 30 in Wt mice or 26 in Sod2 −/+ mice after 3-NP
treatment). *Indicates a significant increase compared with the
Wt mice (P < 0.01 before, P < 0.001 after, unpaired t test). Tx,
treatment; Sod2 −/+, MnSOD-deficient knock-out mice.
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resembled apoptotic bodies (Fig. 4B). Using cresyl violet
staining, these neuronal cells showed fragmented nuclei
(Fig. 4D), and cellular shrinkage and chromatin conden-
sation in the nuclei using hematoxylin and eosin staining
(Fig. 4G), whereas some necrotic cells had light, diffuse
TUNEL-labeled nuclei without apoptotic bodies (Fig.
4C). These cells showed cellular swelling and nuclear
lysis by hematoxylin and eosin staining (Fig. 4F). These
FIG. 2. Increased oxidative DNA injury after 3-NP treatment in
Sod2 −/+ mice. 8-Hydroxyguanosine (8OHG) immunohistochem-
istry after 3-NP treatment for 5 days is shown in (A to D). 8-Hy-
droxyguanosine–positive cells were darkly labeled as granular
particles in the nucleus and cytosol in the wild-type (Wt) mice (A),
and were more widely detected in the Sod2 −/+ mice (B). 8-Hy-
droxyguanosine immunoreactivity was not detected in the other
brain areas of the Wt (C) or Sod2 −/+ (D) mice. Assessment of
8OHG immunoreactivity after DNase or RNase treatment
on the samples treated with 3-NP (E). RNase, RNase-treated;
DNase, DNase-treated; Both, RNase- and DNase-treated;
Buffer, treated with buffer only. This confirmed that DNase treat-
ment almost abolished 8OHG immunoreactivity. Therefore, DNA
oxidation is a main representation of 8OHG immunohistochem-
istry. Bar = 30 µm (A to D); 80 µm (E). Semiquantitation of oxi-
dative DNA injury after 3-NP treatment for 5 days (F). Percentage
of 8OHG-positive cells to total cells was calculated after 3-NP
treatment. Data represent mean ± SD (n = 8 each, Wt or Sod2
−/+ mice). *Indicates a significant increase compared with the Wt
mice (P < 0.001, unpaired t-test). Sod2 −/+, MnSOD-deficient
knockout mice.
FIG. 3. Immunohistochemistry of nitrotyrosine after 3-NP treat-
ment for 5 days. Nitrotyrosine-positive cells are detected in the
striatum of the wild-type (Wt) mice (A) and are widely distributed
and more densely labeled in the striatum of the Sod2 −/+ mice
(B). Immunoreactivity of nitrotyrosine was not detected in the
other brain areas of the Wt (C) or Sod2 −/+ (D) mice. Double
staining of oxidized hydroethidine and nitrotyrosine with fluores-
cent dye (E and F). Nitrotyrosine-positive cells, demonstrated by
fluorescent avidin dye, are green (E), cells with oxidized hydro-
ethidine signals are red (F), and the overlapping section, using
double exposure of fluorescent dye and oxidized hydroethidine,
is expressed as yellow (G). Semiquantitation of nitrotyrosine for-
mation after 3-NP treatment for 5 days (H). Percentage of nitro-
tyrosine-positive cells to total cells was calculated after 3-NP
treatment. Data represent mean ± SD (n = 10 each, Wt or Sod2
−/+ mice). *Indicates a significant increase compared with the Wt
mice (P < 0.001, unpaired t-test). Sod2 −/+, MnSOD-deficient
knockout mice.
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results are consistent with those of previous reports, in
which the coexistence of cells with either necrotic or
apoptotic features were observed in the lesioned striatum
after 3-NP treatment (Kim et al., 2000a) and in which
necrotic neurons were slightly labeled using TUNEL
staining (Kondo et al., 1997).
Decortication prevented the production of O2•− and
DNA and striatal injury in Sod2 −/+ mice
After cresyl violet staining, the lateral portion of the
intact striatum in the decorticated Sod2 −/+ mice was
pale after 3-NP treatment for 5 days (Fig. 5A). To de-
termine the relation between excitotoxicity and the in-
duction of apoptosis after 3-NP treatment in the Sod2 −/+
mice, we evaluated DNA fragmentation by TUNEL
staining in the decorticated Sod2 −/+ mice (n  20).
TUNEL-labeled cells (1,690 ± 209/mm2, mean ± SD )
were markedly detected in the intact striatum, but not in
the denervated striatum (Figs. 5B and 5C). To determine
the relation between the induction of O2•− and excitotox-
icity after 3-NP treatment in the Sod2 −/+ mice, we
evaluated O2•− production using in situ detection with
hydroethidine after 3-NP treatment in the striatum. In the
intact striatum, oxidized hydroethidine signals were
markedly detected, but not in the denervated striatum
(Figs. 5D and 5E). The data on oxidized hydroethidine
in the intact striatum of the decorticated Sod2 −/+ mice
FIG. 5. Representative photomicrographs showing that decorti-
cation prevented oxidative stress and subsequent striatal injury in
the Sod2 −/+ mice. Using cresyl violet staining, the lateral section
of the intact striatum in the decorticated mice was pale after 3-NP
treatment for 5 days (A). TUNEL-positive cells were not detected
in the denervated striatum (B), whereas they were markedly de-
tected in the intact striatum of the Sod2 −/+ mice after 3-NP
treatment for 5 days (C). Oxidized hydroethidine signals as an
indication of O2•− production (red) were barely seen in the dener-
vated striatum of the Sod2 −/+ mice after 3-NP treatment for 2
days (D) and were widely and strongly expressed in the intact
striatum (E). 8-Hydroxyguanosine immunoreactivity was not seen
in the denervated striatum of the Sod2 −/+ mice after 3-NP treat-
ment for 5 days (F), but was markedly detected in the intact
striatum (G). Bars = 1 mm (A); 100 µm (B to G). Sod2 −/+,
MnSOD-deficient knockout mice.
FIG. 4. Representative findings showing increased DNA ladder-
ing in the striatum of the Sod2 −/+ mice after 3-NP treatment.
DNA gel electrophoresis after 3-NP treatment for 5 days (A).
DNA laddering, as evidence of apoptosis, was detected in the
striatum accompanied by a diffuse and weak smearing pattern,
as evidence of necrosis. The amount of DNA laddering was
markedly increased in the Sod2 −/+ mice (lane 3) compared with
the wild-type (Wt) mice (lane 4). Similar results were obtained in
10 independent studies. MW, molecular weight; Control, un-
treated control striatum; Sod2 −/+, mutant mice with MnSOD de-
ficiency. Characteristic findings of apoptosis or necrosis with dif-
ferent stainings (B to G). TUNEL-labeled cells accompanied
by small particles around the nuclei that resemble apoptotic
bodies (B). Necrotic cells had light and diffuse TUNEL-labeled
nuclei without apoptotic bodies (C). Using cresyl violet staining,
some cells corresponding to apoptosis showed fragmented
nuclei (arrowhead) (D). With hematoxylin and eosin staining, the
nuclear and cellular morphology of the neurons in the normal
striatum was characterized by a smooth nuclear membrane
and uniform chromatin formation (E). Necrotic cells had cellular
swelling and nuclear lysis (arrowhead) (F). Apoptotic cells had
shrinkage and chromatin condensation in the nuclei (arrowhead)
(G). Bar = 15 µm (B to G). Sod2 −/+, MnSOD-deficient knockout
mice.
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were not different from the results in the striatum of
the Sod2 −/+ mice after 3-NP treatment. For determin-
ing oxidative DNA injury during excitotoxicity, we
evaluated 8-hydroxyguanosine immunoreactivity in
3-NP–treated decorticated Sod2 −/+ mice. The immuno-
histochemistry of 8-hydroxyguanosine in the intact stria-
tum detected densely labeled nuclei and/or coarse granu-
lar immunodeposits in the cytoplasm of neuronal cells
and in the nuclei of shrunken cells. Immunoreactivity of
8-hydroxyguanosine was completely unlabeled in the de-
nervated lesioned striatum (Figs. 5F and 5G). The data
on 8-hydroxyguanosine in the intact striatum of the de-
corticated Sod2 −/+ mice were not different from the
results in the striatum of the Sod2 −/+ mice after 3-NP
treatment.
Striatal lesion volume and DNA fragmentation were
advanced in the Sod2 −/+ mice, but attenuated by
overexpression of copper/zinc superoxide dismutase
To determine whether oxidative stress, particularly
caused by O2•−, is involved in striatal vulnerability after
3-NP treatment, the lesion volume and DNA fragmenta-
tion were evaluated in the Wt and Sod2 −/+ mice using
TUNEL staining. Furthermore, to clarify the involve-
ment of O2•− in selective striatal vulnerability in the Sod2
−/+ mice after 3-NP treatment, SOD1 +/− / Sod2 −/+
mice were treated with 3-NP. After 3-NP treatment for 5
days, the Wt mice had striatal lesions, particularly in the
lateral portion, by cresyl violet staining (Fig. 6A). The
Sod2 −/+ mice had increased lesions in the striatum com-
pared with the Wt mice (Fig. 6B). The SOD1 +/− / Sod2
−/+ mice had very small lesions in the lateral part of the
striatum (Fig. 6C). No lesions were seen in the hippo-
campus or other brain area (data not shown). TUNEL
staining was visualized with dark-field phase-contrast
microscopy to evaluate the distribution of apoptotic and
necrotic neurons in the lesioned striatum. Apoptosis and
necrosis could be morphologically distinguished, al-
though whether TUNEL-labeled cells are exactly apop-
totic cells is still a controversial issue. A bright yellow
represented TUNEL-positive apoptotic neurons and a
faint yellow represented necrotic neurons, using a yellow
filter with dark-field phase-contrast microscopy (Kondo
et al., 1997). In the Wt mice, TUNEL-positive apoptotic
neurons were observed in the lesioned striatum (Fig.
6D). In the Sod2 −/+ mice, TUNEL-positive cells were
more prominent and widely distributed in the lesioned
striatum (Fig. 6E). In the SOD1 +/− / Sod2 −/+ mice,
bright yellow, TUNEL-positive cells were barely de-
tected in a small striatal lesion (Fig. 6F). As illustrated in
Figs. 6G and 6H, we quantified and compared the lesion
volume percentage and TUNEL-positive cells in three
groups under bright-field microscopy. The percentage of
lesion volume was significantly increased in the Sod2
−/+ mice compared with the Wt mice, but CuZnSOD
FIG. 6. Striatal lesion volume and DNA fragmentation in Sod2
−/+ mice or SOD1 +/− / Sod2 −/+ mice after 3-NP treatment.
Cresyl violet staining after 3-NP treatment for 5 days (A to C). The
striatum in the Wt mice had a pale lesion laterally (A), and a huge
striatal lesion was detected in the Sod2 −/+ mice (B). The SOD1
+/− / Sod2 −/+ mice had a small lesion in the striatum (C). TUNEL
staining visualized with dark-field phase-contrast microscopy us-
ing a yellow filter after 3-NP treatment for 5 days (D to F). Bright
yellow represents TUNEL-positive apoptotic neurons, and a faint
yellow represents necrotic neurons. In the wild-type (Wt) mice,
TUNEL-positive cells were detected in the lesioned lateral stria-
tum (D), and were densely distributed in the entire large, lesioned
striatum of the Sod2 −/+ mice (E). TUNEL-positive cells were
hardly detected in the lesioned striatum of the SOD1 +/− / Sod2
−/+ mice (F). Bars = 1 mm (A to C), 500 µm (D to F). Quantitation
of lesion volume after 3-NP treatment for 5 days (G). The per-
centage of lesion volume to striatal volume was calculated. Data
represent mean ± SD (n = 30 each, Wt or Sod2 −/+ mice or 12
SOD1 +/− / Sod2 −/+ mice). Quantitation of TUNEL-positive cells
after 3-NP treatment for 5 days (H). TUNEL-positive cells were
counted and expressed as cells/mm2 under bright-field micros-
copy (×400). Data represent mean ± SD (n = 30 each, Wt or Sod2
−/+ mice or 12 SOD1 +/− / Sod2 −/+ mice). *Indicates a signifi-
cant increase compared with the Wt mice and **indicates a sig-
nificant decrease compared with the Sod2 −/+ or Wt mice (P <
0.001, Fisher’s protected least-significant difference test). Sod2
−/+, MnSOD-deficient knockout mice; SOD1 +/− / Sod2 −/+,
Sod2 −/+ mice that overexpress CuZnSOD.
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overexpression significantly attenuated the lesion vol-
ume percentage in the SOD1 +/− / Sod2 −/+ mice com-
pared with the other groups (Fig. 6G). In the Sod2 −/+
mice, there was a significantly increased number of
TUNEL-positive cells/mm2 compared with the Wt mice,
whereas CuZnSOD overexpression significantly attenu-
ated TUNEL-positive cells in the SOD1 +/− / Sod2 −/+
mice compared with the other groups (Fig. 6H).
DISCUSSION
We demonstrated that oxidative cellular injury and
subsequent DNA fragmentation through the overproduc-
tion of reactive oxygen species (ROS), in particular O2•−,
were exacerbated after 3-NP treatment in Sod2 −/+ mice,
whereas decortication completely abolished the produc-
tion of O2•−, and subsequent DNA fragmentation and
oxidative striatal damage. We also showed that increased
CuZnSOD attenuated 3-NP–induced DNA fragmenta-
tion and striatal damage in Sod2 −/+ mice that overex-
press CuZnSOD. Our findings suggest that MnSOD may
play a role in defending against 3-NP–induced oxidative
DNA and cellular injury, thereby lessening subsequent
cell demise by the decrease in O2•− production. More-
over, O2•− may be involved in the signaling mechanism
of selective striatal vulnerability through the interacting
excitotoxic cascade after 3-NP treatment. These findings
are consistent with previous results in vitro that showed
that use of cell cultures from transgenic mice that over-
express MnSOD attenuated 3-NP–induced apoptosis or
necrosis by the decrease in superoxide formation and
subsequent calcium release from mitochondria (Bruce-
Keller et al., 1999), or that overexpression of MnSOD
prevented apoptosis induced by free-radical generating
agents through the suppression of peroxynitrite and lipid
peroxidation (Keller et al., 1998b), or results in vivo that
showed that increased ROS were detected in 3-NP–
induced striatal lesions (Beal et al., 1995; Schulz et al.,
1996; Bogdanov et al., 1999), and that decortication re-
duced striatal lesions after systemic 3-NP injection in
rats or mice (Beal et al., 1993; Fu et al., 1995).
In fact, recent studies have linked excitotoxicity and
ROS production to mitochondrial dysfunction. A failure
of energy production caused by mitochondrial dysfunc-
tion may lead to membrane depolarization, removal of
the voltage-dependent Mg2+ block of the NMDA recep-
tor, and subsequent activation of the NMDA receptor.
During these episodes, increased intracellular calcium
levels can initiate a number of deteriorative processes
such as proteinase activation and free radical generation
(Novelli et al., 1988; Beal et al., 1993; Coyle and Putt-
farcken, 1993). Moreover, ROS produced by NMDA-
receptor activation mediate further enhancing excitotox-
icity and subsequent cell death (Schulz et al., 1995). In
the present study, the effects of MnSOD deficiency on
the increase in O2•− production in the striatum and sub-
sequent striatal lesion volume after 3-NP treatment, and
decortication in the Sod2 −/+ mice to prevent O2•− pro-
duction in the striatum and oxidative striatal damage,
suggest that the production of O2•− and the excitotoxic
cascade may interact to produce selective striatal vulner-
ability after 3-NP treatment. Our recent report showed
that decortication prevented O2•− production in the stria-
tum and subsequent DNA fragmentation and striatal vul-
nerability after 3-NP treatment in Wt mice (Kim et al.,
2000a). Thus, the present results showing that the decor-
ticated Sod2 −/+ mice may be more susceptible to O2•−
production after 3-NP treatment than the Wt mice, sug-
gest that O2•− associated with excitotoxicity may produce
DNA fragmentation and selective striatal damage after
3-NP treatment. Furthermore, a low dose of 3-NP (50
mg/kg twice a day) was used according to our previous
data, which confirmed that a low-dose 3-NP treatment
(60 mg/kg twice a day) produced typical features of
NMDA-receptor–mediated excitotoxic striatal lesions,
such as the sparing of NADPH diaphorase neurons and
attenuation by the NMDA-receptor antagonist or decor-
tication (Kim et al., 2000a). It has been reported that
formation of O2•− is an obligatory step for excitotoxic
cell death in rat cortical cell cultures (Patel et al., 1996),
and that reduced MnSOD exacerbates glutamate-induced
neuronal death in cultured mouse cortical neurons (Li et
al., 1998). Thus, it is conceivable that ROS, particularly
O2•−, overproduced against the scavenging capability of
MnSOD by activation of the NMDA receptor after 3-NP
treatment, could produce selective striatal damage. A
previous report showing that partial inhibition of brain
succinate dehydrogenase (SDH) by systemic low-dose
but repetitive 3-NP treatment may be enough to produce
selective striatal lesions in rats and that the inhibition of
SDH occurred in other brain regions in the same manner
as in the striatum (Brouillet et al., 1998). This suggests
that selective striatal vulnerability after 3-NP treatment
may be related to other provocative factors such as pref-
erential occurrence of excitotoxicity or oxidative stress
in the striatum rather than selective SDH inhibition by
3-NP in the striatum. Our present study showed that in-
creased O2•− production and oxidative DNA or cellular
damage, which are associated with excitotoxicity,
selectively occurred in the striatum, supporting this
hypothesis.
Although the gene defect as an expansion in unstable
trinucleotide repeats on chromosome 4 and has been
identified in HD, which is a main target disease of
the 3-NP animal model, the exact pathogenetic mecha-
nisms of abnormal gene expression are not clear (The
Huntington’s Disease Collaborative Research Group,
1993). The failure of mitochondrial energy metabolism
linked to oxidative stress has been drawing more atten-
tion regarding the mechanism of selective basal ganglia
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vulnerability in HD (Gu et al., 1996; Petersén et al.,
1999; Beal, 2000). The present data showing that Mn-
SOD deficiency increases oxidative DNA damage and
fragmentation suggest that apoptotic cell death may be
provoked by oxidative stress, in particular by O2•− pro-
duction, after 3-NP treatment in the striatum of Sod2 −/+
mice. Recent evidence of apoptotic cell death in 3-NP
experiments or HD postmortem studies suggests that
both necrosis and apoptosis may be involved in the
pathogenesis of HD, whereas excitotoxic neuronal cell
death has been traditionally considered to be necrotic
(Portera-Cailliau et al., 1995; Pang and Geddes, 1997;
Sato et al., 1997; Kim et al., 2000a; Kim and Chan,
2001). Mitochondrial function plays a pivotal role in the
development of apoptosis or necrosis according to the
severity of the mitochondrial energy failure during exci-
totoxic neuronal cell death (Ankarcrona et al., 1995;
Bonfoco et al., 1995; Chan, 2001). Our present data are
consistent with previous studies using Sod2 −/+ mice in
which O2•− production may have mediated early cyto-
chrome c release from mitochondria or oxidative mito-
chondrial damage and subsequent infarct after focal ce-
rebral ischemia (Murakami et al., 1998; Fujimura et al.,
1999). Moreover, our previous reports showed that the
systemic 3-NP treatment model in mice or rats may pro-
duce initial apoptotic cell death and subsequently both
apoptosis and necrosis in the striatum after repetitive
treatment (Sato et al., 1997; Kim et al., 2000a; Kim and
Chan, 2001). As seen in the present study, increased
nitrotyrosine immunoreactivity in Sod2 −/+ mice after
3-NP treatment, and nitrotyrosine-positive cells showing
O2•− production in the cytosol confirm that oxidative
cellular injury after 3-NP treatment might contribute to
the mechanism of selective striatal vulnerability along
with the production of O2•−, because the nitration of
tyrosines of cellular proteins is formed by peroxynitrite
as a result of the reaction with O2•− and nitric oxide
radical (Chan, 1996). Our findings agree with those in
previous reports showing that intrastriatal NMDA injec-
tion produced nitrotyrosine formation and DNA frag-
mentation in the lesioned striatum of mice (Ayata et al.,
1997) or that nitrotyrosine immunoreactivity increased in
the infarcted tissue after focal cerebral ischemia in mice
(Eliasson et al., 1999). An attractive feature of the hy-
pothesis of oxidative stress as a mechanism of chronic
neurodegeneration is that it can account for the cumula-
tive damage associated with the delayed onset and pro-
gressive nature of HD or other neurodegenerative disor-
ders (Coyle and Puttfarcken, 1993; Kim and Chan,
2001). In addition, apoptosis has characteristics of slow
and delayed cell death compared with necrosis (Choi,
1988; Meldrum, 1993). Thus, oxidative stress-related
apoptotic neuronal death in the striatum induced by 3-NP
should provide useful information to better our under-
standing of chronic neurodegenera tive disorders.
In this study, to our surprise, overexpressed CuZnSOD
significantly attenuated DNA fragmentation and lesion
volume after 3-NP treatment in SOD1 +/− / Sod2 −/+
mice compared with pure Sod2−/+ mice or even Wt
mice. Recent studies using confocal and electron micros-
copy, proposed the compartmentalization of MnSOD,
which is located only in mitochondria, and CuZnSOD,
which is located uniformly throughout the nuclear and
cytoplasmic matrix (Slot et al., 1986; Crapo et al., 1992;
Lindenau et al., 2000). Thus, the present data suggest
that the main effects of O2•− overproduced from mito-
chondria after 3-NP treatment may be related to cytosolic
events such as NMDA activation rather than direct mi-
tochondrial collapse in this experimental system. A pre-
vious report using SOD1 transgenic mice, the same strain
used in the present study, clearly showed that CuZnSOD
attenuates 3-NP neurotoxicity by reduction of ROS (100
mg·kg−1/d for 5 days) (Beal et al., 1995). In addition, this
protective effect of overexpressed CuZnSOD in SOD1
+/− / Sod2 −/+ mice may occur because of the discrep-
ancy in increased or decreased levels between CuZnSOD
in the cytosol (3× increase) (Epstein et al., 1987) and
MnSOD in mitochondria (50% decrease) (Chan et al.,
1996). Furthermore, mitochondria are a main source of
O2•−, which is freely transported into the cytosol, in the
process of excitotoxicity (Dugan et al., 1995; Chan,
1996). Thus, we can speculate that the excitotoxic cas-
cade activated by mitochondrial dysfunction after 3-NP
treatment may produce O2•− against the scavenging ac-
tivity of MnSOD in the mitochondria, and then O2•− may
further enhance the excitotoxic process, which subse-
quently produces more O2•−, and finally, the integrated
oxidative-excitotoxicity process may produce selective
striatal damage. In our present study, oxidized hydroethi-
dine signals were remarkably detected in the lateral stria-
tum, which is a main lesioned striatum, after 3-NP treat-
ment. This is in agreement with the current hypothesis
that ROS, in particular O2•−, linked to excitotoxicity may
mediate striatal vulnerability after 3-NP treatment.
In conclusion, our study demonstrated that production
of O2•− linked to the excitotoxic cascade may be a critical
step in selective striatal vulnerability, promoted by oxi-
dative DNA injury and DNA fragmentation after 3-NP
treatment.
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